- Advertisement -

Nasdaq Biotechnology ─ tag

Latest articles

Rhenman downplays risk of US price regulation of pharmaceuticals

Stockholm (HedgeNordic) - In September, shares of companies within healthcare and biotech saw another round of sharp declines. The Nasdaq Biotechnology Index dropped more...

Popular Posts